XML 23 R7.htm IDEA: XBRL DOCUMENT v3.3.1.900
Statement of Cash Flows
$ in Thousands
12 Months Ended
Dec. 31, 2015
USD ($)
Dec. 31, 2014
USD ($)
Dec. 31, 2013
USD ($)
CASH FLOWS FROM OPERATING ACTIVITIES:      
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $ 114,932 $ 258,626 $ 243,194
Adjustments to reconcile income to net cash provided by operating activities:      
Share-based Compensation 21,279 20,470 20,526
Depreciation and amortization 27,457 26,696 25,471
Debt issuance costs amortization and finance charges 702 445 480
(Increase) decrease in value of life insurance policies 909 (1,581) (5,112)
Deferred Income Tax Expense (Benefit) (107) 4,682 6,790
Asset Impairment Charges 5,199 0 0
Provision for Doubtful Accounts 2,592 1,243 (236)
Other Noncash Income (Expense) (860) (466) 473
Changes in assets and liabilities, net of effects of acquisitions:      
Accounts receivable 49,261 3,486 (16,312)
Inventories 3,049 2,894 1,291
Prepaid expenses and other current assets 7,744 (10,088) 13,915
Other assets 2,652 680 (867)
Accounts payable (13,353) (3,021) (6,339)
Accrued expenses (9,723) (2,611) 5,979
Other long-term liabilities 4,275 1,873 11,865
Increase (Decrease) in Deferred Revenue 3,092 121 (2,981)
Net cash provided by operating activities 219,100 303,449 298,137
CASH FLOWS FROM INVESTING ACTIVITIES:      
Capital expenditures (22,797) (36,586) (35,416)
Patents and other intangibles (1,460) (854) (3,530)
Acquisitions, net of cash acquired (13,774) (1,200) 0
Payments for (Proceeds from) Investments 0 0 (98)
Proceeds from sale of assets 1,320 884 1,036
Proceeds from insurance recovery 0 0 1,385
Premiums on life insurance (2,943) (4,310) (6,575)
Net cash used in investing activities (39,654) (42,066) (43,198)
CASH FLOWS FROM FINANCING ACTIVITIES:      
Repayment of debt borrowings (139,656) (128,162) (134,046)
Proceeds from debt borrowings 215,000 217,000 167,000
Stock options exercised 0 0 83
Excess tax benefits from stock-based payments (175) 3,020 3,744
Debt financing costs (387) (1,128) 0
Non-controlling interest - dividend (1,140) (394) 0
Dividends paid (94,235) (89,089) (58,642)
Repurchase of common shares (159,709) (264,368) (227,216)
Net cash used in financing activities (180,302) (263,121) (249,077)
NET CHANGE IN CASH AND CASH EQUIVALENTS (856) (1,738) 5,862
Cash and Cash Equivalents, at Carrying Value 22,494 23,350 25,088
Cash payments for interest 12,313 10,272 8,869
Cash payments for income taxes 35,523 79,644 57,001
Non-cash investing and financing activities:      
Financed capital expenditures 483 1,009 5,797
Insurance premium financed $ 2,228 $ 0 $ 0